Clostridium difficile

May 14, 2019

Mobidiag Secures €25M Loan to Build Test Menu

May 13, 2019

Roche Diagnostics, Beckman Coulter, Sekisui Diagnostics, Others Receive FDA Clearances in April

May 2, 2019

Meridian Biosciences Expects MDx Business Rejuvenation With GenePOC Acquisition
Premium

Mar 4, 2019

MALDI-TOF, Rapid Molecular Testing Strategy Fuel Outreach Growth for Cayuga Medical Center Lab
Premium

Jan 3, 2019

Clostridium Difficile Diagnosis May be Expedited by Nanoparticle Point-of-Care Biosensor
Premium

Nov 28, 2018

Johns Hopkins Researchers Working on Tool to Combat C. Difficile Overtesting
Premium

Nov 8, 2018

Meridian Bioscience Q4 Revenues Grow 7 Percent

Oct 23, 2018

GenePOC's Investment in Small Molecular Diagnostic Panels Validated by Medicare Decision, Company Says
Premium

Oct 23, 2018

GenePOC C. Diff MDx Approved in Canada

Jul 31, 2018

Meridian Bioscience Q3 Revenues Grow 3 Percent

Jun 19, 2018

First Light Bio Developing Single-Molecule Counting Tech to Detect C. Diff. Toxins
Premium

Apr 24, 2018

Meridian Eyes Physician Office Space With Curian Immunoassay Reader
Premium

Apr 11, 2018

First Light Biosciences Developing Rapid Syndromic ID/AST System Using Digital Imaging
Premium

Jan 12, 2018

JPM Healthcare Day 4: Luminex, Natera, and Oxford Immunotec

Dec 12, 2017

Heroin Detection Assay, Kidney Injury System Cleared by FDA in November

Nov 28, 2017

GenePOC C. Diff Test Receives FDA Approval

Nov 27, 2017

Interlux to Distribute Mobidiag Products in Estonia

Oct 9, 2017

Roche C. difficile Assay Among FDA-Cleared Tests in September

Aug 7, 2017

Luminex Q2 Revenues Up 19 Percent; Firm to Delay Verigene 2 FDA Submission

Jul 27, 2017

Meridian Bio Q3 Revenues Inch Down 1 Percent